Weight-Loss Medication Fills Across the U.S.

Combined fill rate fill rate for Ozempic, Wegovy, Mounjaro, Zepbound, Victoza, Saxenda, liraglutide, Qsymia, and phentermine is shown.

We calculated the fill rate by taking the fill count of weight-loss medications as a percentage of fills for all medications (excluding vaccines) from January 1, 2023 through October 31, 2024. Ozempic, Mounjaro, Victoza, and liraglutide are prescribed for Type 2 diabetes. Wegovy, Zepbound, Saxenda, Qsymia, and phentermine are prescribed for weight loss.
GoodRx (yellow logo)